Zur Hauptnavigation wechseln
Zur Suche wechseln
Zum Hauptinhalt wechseln
Technische Universität München Home
Hilfe und FAQ
English
Deutsch
Home
Personen
Einrichtungen
Projekte
Publikationen
Ausstattungen/Einrichtungen
Auszeichnungen
Aktivitäten
Presseberichte
Nach Expertise, Namen oder Zugehörigkeit suchen
Cellular therapy
Hans Jochem Kolb
, Reinhold Munker
Klinik und Poliklinik für Innere Medizin III, Hämatologie und Onkologie
Louisiana State University Health Sciences Center-Shreveport
Publikation
:
Beitrag in Buch/Bericht/Konferenzband
›
Kapitel
›
Begutachtung
Übersicht
Fingerprint
Fingerprint
Untersuchen Sie die Forschungsthemen von „Cellular therapy“. Zusammen bilden sie einen einzigartigen Fingerprint.
sortieren
Gewicht:
Alphabetisch
Keyphrases
Cell Therapy
100%
Relapse Rate
60%
Cell-to-cell
40%
Stem Cells
40%
T Cells
40%
Natural Killer Cells
40%
Dendritic Cells
40%
Leukemia
40%
Hematopoietic Stem Cells
40%
Mesenchymal Stem Cells
20%
Europe
20%
Induced Pluripotent Stem Cells (iPSCs)
20%
Lymphocytes
20%
Orthopedics
20%
Malignant Disease
20%
Adoptive Immunotherapy
20%
Cell Cytokines
20%
B Lymphocytes
20%
Regulatory T Cells
20%
Human Patients
20%
Monocytes
20%
High-dose Chemotherapy
20%
High-dose Therapy
20%
Progenitor Cells
20%
Hematopoiesis
20%
Genetically Modified T Cells
20%
Allogeneic
20%
Cytokine-induced Killer Cells
20%
Hematologic
20%
Allogeneic HSCT
20%
Stem Cell Progenitors
20%
Mature Cell
20%
High-dose Radiotherapy
20%
Blood Disorders
20%
T Cell Depletion
20%
Medicine and Dentistry
Cell Therapy
100%
T Cell
60%
Recurrence Risk
60%
Cardiovascular System
40%
Hematopoietic Cell
40%
Stem Cell
40%
Leukemia
40%
Dendritic Cell
40%
Graft Versus Host Reaction
40%
Natural Killer Cell
40%
Mesenchymal Stem Cell
20%
Drug Megadose
20%
T Lymphocyte
20%
Orthopedics
20%
B Lymphocyte
20%
Regulatory T Cell
20%
Induced Pluripotent Stem Cell
20%
Adoptive Immunotherapy
20%
Chronic Myelogenous Leukemia
20%
High Dose Chemotherapy
20%
Acute Myelogenous Leukemia
20%
Cytokine Induced Killer Cell
20%
Sulfhemoglobinemia
20%
Progenitor Cell
20%
Hematopoiesis
20%
Lymphocyte
20%
Diseases
20%
Radiation Therapy
20%
Acute Lymphocytic Leukemia
20%
Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
T Cell
100%
Drug Megadose
66%
Dendritic Cell
66%
Natural Killer Cell
66%
Hematopoietic Cell
66%
Hematopoiesis
33%
Induced Pluripotent Stem Cell
33%
T Cell Depletion
33%
B Cell
33%
Progenitor Cell
33%
Cytokine
33%
Regulatory T Cell
33%
Lymphocyte
33%
Neuroscience
T Cell
100%
Cell Therapy
100%
Stem Cell
60%
Natural Killer Cell
40%
Hematopoietic Cell
40%
Mesenchymal Stem Cell
20%
B Cell
20%
Immunotherapy
20%
Progenitor Cell
20%
Hematopoiesis
20%
Lymphocyte
20%
Radiation Therapy
20%
Cytokine
20%
Pharmacology, Toxicology and Pharmaceutical Science
Recurrence Risk
100%
Graft Versus Host Reaction
66%
Leukemia
66%
High Dose Chemotherapy
33%
Cytokine
33%
Hematologic Disease
33%
Immunotherapy
33%
Diseases
33%